The Application and Impact of Digital Patient Decision Aids in COPD: A Scoping Review.

AIMS: This review aimed to systematically examine the application of digital patient decision aids in patients with chronic obstructive pulmonary disease, clarify the main decision-making themes and core content of current digital patient decision aids for patients with chronic obstructive pulmonary disease, and summarise the scope and characteristics of reported outcome evidence related to these tools. DESIGN: Existing research on digital patient decision aids for patients chronic obstructive pulmonary disease was summarised. DATA SOURCES: We retrieved the PubMed, Web of Science, Cochrane and Embase databases from their establishment to 31 July 2025. METHODS: This scoping review was reported in accordance with the PRISMA Extension for Scoping Reviews reporting guideline. Search terms included decision-making support technology, chronic obstructive pulmonary disease and related topics. The inclusion standard is based on the principle of PCC. The study population is chronic obstructive pulmonary disease patients, the core concept is digital patient decision aids and the environment is family, community or hospital. RESULTS: A total of nine studies were included. The results showed that the digital patient decision aids mainly focused on the two major decision-making topics of pulmonary rehabilitation and mechanical ventilation. These measures are mainly implemented through web pages, recordings or clinical decision support systems. In terms of result indicators, most studies choose decision-making conflict as an indicator of decision-making quality. In addition, satisfaction, acceptability, knowledge and other result indicators have also received some attention. CONCLUSION: Preliminary evidence indicates that digital patient decision aids show promise for supporting shared decision-making in COPD. Current data suggest a positive trend in decision-making quality, but the evidence base is limited by few included studies and heterogeneous designs. Large, well-designed trials are required to confirm their sustained effects on decision-making outcomes and long-term clinical impact. NO PATIENT OR PUBLIC CONTRIBUTIONS: This scoping review did not include any patients or public involvement.